{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:50:14Z","timestamp":1789789814364,"version":"4.0.1"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2015CB553504"],"award-info":[{"award-number":["2015CB553504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Project of Beijing Natural Science Foundation","award":["7131010"],"award-info":[{"award-number":["7131010"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ejphar.2016.03.040","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T06:44:00Z","timestamp":1458801840000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction"],"prefix":"10.1016","volume":"780","author":[{"given":"Dan-Ni","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.03.040_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.282.5387.298","article-title":"Transition from moderate to excessive drug intake: change in hedonic set point","volume":"282","author":"Ahmed","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2016.03.040_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2011.07.007","article-title":"Modafinil for the treatment of methamphetamine dependence","volume":"120","author":"Anderson","year":"2012","journal-title":"Drug. Alcohol Depend."},{"key":"10.1016\/j.ejphar.2016.03.040_bib3","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/sj.npp.1300454","article-title":"Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade","volume":"29","author":"Anggadiredja","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.040_bib4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.brainres.2004.06.051","article-title":"Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward","volume":"1021","author":"Anggadiredja","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.040_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug. Rev."},{"key":"10.1016\/j.ejphar.2016.03.040_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/1516-4446-2013-1244","article-title":"Systematic review of N-acetylcysteine in the treatment of addictions","volume":"36","author":"Asevedo","year":"2014","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.ejphar.2016.03.040_bib7","first-page":"18","article-title":"Preclinical assessment of lisdexamfetamine as an agonist medication candidate for cocaine addiction: effects in rhesus monkeys trained to discriminate cocaine or to self-administer cocaine in a cocaine versus food choice procedure","author":"Banks","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopsych.2015.01.004","article-title":"How preclinical models evolved to resemble the diagnostic criteria of drug addiction","volume":"79","author":"Belin-Rauscent","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1369-1600.2011.00428.x","article-title":"Extended access to cocaine self-administration results in reduced glutamate function within the medial prefrontal cortex","volume":"17","author":"Ben-Shahar","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib10","first-page":"525","article-title":"Review of bupropion","volume":"2","author":"Bryant","year":"1983","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.ejphar.2016.03.040_bib11","doi-asserted-by":"crossref","first-page":"13140","DOI":"10.1523\/JNEUROSCI.2284-07.2007","article-title":"Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice","volume":"27","author":"Caine","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.040_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2014.09.026","article-title":"A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats","volume":"743","author":"Chen","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainresbull.2005.05.028","article-title":"Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone","volume":"67","author":"Chiu","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2016.03.040_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pop.2010.11.004","article-title":"Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy","volume":"38","author":"Ciccarone","year":"2011","journal-title":"Prim. Care."},{"key":"10.1016\/j.ejphar.2016.03.040_bib15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archgenpsychiatry.2011.124","article-title":"Mirtazapine to reduce methamphetamine use: a randomized controlled trial","volume":"68","author":"Colfax","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00213-007-0827-7","article-title":"A conflict rat model of cue-induced relapse to cocaine seeking","volume":"194","author":"Cooper","year":"2007","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.ejphar.2016.03.040_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2014.08.003","article-title":"Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature","volume":"143","author":"Courtney","year":"2014","journal-title":"Drug. Alcohol Depend."},{"key":"10.1016\/j.ejphar.2016.03.040_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pbb.2013.10.018","article-title":"Pharmacogenetics of OPRM1","volume":"123","author":"Crist","year":"2014","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.ejphar.2016.03.040_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.ejphar.2016.03.040_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00054-6","article-title":"Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment","volume":"36","author":"Davidson","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2016.03.040_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1017\/S1461145708008456","article-title":"Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers","volume":"11","author":"De La Garza","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pbb.2007.12.010","article-title":"The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers","volume":"89","author":"De La Garza","year":"2008","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2016.03.040_bib23","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1126\/science.1099020","article-title":"Evidence for addiction-like behavior in the rat","volume":"305","author":"Deroche-Gamonet","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2016.03.040_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.biopsych.2008.12.008","article-title":"High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence","volume":"65","author":"Economidou","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1360-0443.2011.03771.x","article-title":"Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial","volume":"107","author":"Elkashef","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2016.03.040_bib26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","article-title":"Bupropion for the treatment of methamphetamine dependence","volume":"33","author":"Elkashef","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.040_bib27","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.neubiorev.2013.02.010","article-title":"From the ventral to the dorsal striatum: devolving views of their roles in drug addiction","volume":"37","author":"Everitt","year":"2013","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.ejphar.2016.03.040_bib28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2125.2012.04474.x","article-title":"Future pharmacological treatments for substance use disorders","volume":"77","author":"Forray","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/clpt.2010.307","article-title":"A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction","volume":"89","author":"Galloway","year":"2011","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.ejphar.2016.03.040_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.euroneuro.2010.06.018","article-title":"A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence","volume":"20","author":"Grant","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbr.2008.08.021","article-title":"The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat","volume":"197","author":"Haggkvist","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.040_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neuropharm.2013.05.021","article-title":"A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to d-amfetamine, methylphenidate and modafinil","volume":"73","author":"Heal","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2016.03.040_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present--a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/08039480510023052","article-title":"An open clinical trial of naltrexone for amphetamine dependence: compliance and tolerability","volume":"59","author":"Jayaram-Lindstrom","year":"2005","journal-title":"Nord J. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib35","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","article-title":"Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial","volume":"165","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib36","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","article-title":"Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence","volume":"33","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.040_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FBP.0b013e3283423d55","article-title":"Naltrexone decreases d-amphetamine and ethanol self-administration in rhesus monkeys","volume":"22","author":"Jimenez-Gomez","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejphar.2015.06.019","article-title":"Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction","volume":"761","author":"Jing","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2165\/00023210-200418150-00005","article-title":"Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment","volume":"18","author":"Johnson","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2016.03.040_bib40","first-page":"917","article-title":"The pharmacology and toxicology of ecstasy (MDMA) and related drugs","volume":"165","author":"Kalant","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.ejphar.2016.03.040_bib41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrn2515","article-title":"The glutamate homeostasis hypothesis of addiction","volume":"10","author":"Kalivas","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.040_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug. Alcohol Depend."},{"key":"10.1016\/j.ejphar.2016.03.040_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","article-title":"Pharmacological approaches to methamphetamine dependence: a focused review","volume":"69","author":"Karila","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib44","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archgenpsychiatry.2012.1a","article-title":"Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence","volume":"69","author":"Krupitsky","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib45","first-page":"63","article-title":"Involvement of cannabinoid CB1 and CB2 receptor activity in the development of behavioural sensitization to methamphetamine effects in mice","volume":"27","author":"Landa","year":"2006","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.ejphar.2016.03.040_bib46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1515\/revneuro-2012-0066","article-title":"Compulsive drug use and its neural substrates","volume":"23","author":"Lesscher","year":"2012","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.040_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fnana.2011.00041","article-title":"The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons","volume":"5","author":"Lobo","year":"2011","journal-title":"Front Neuroanat."},{"key":"10.1016\/j.ejphar.2016.03.040_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1360-0443.2009.02717.x","article-title":"Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence","volume":"105","author":"Longo","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2016.03.040_bib49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2012.10.009","article-title":"Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis","volume":"130","author":"Ma","year":"2013","journal-title":"Drug. Alcohol Depend."},{"key":"10.1016\/j.ejphar.2016.03.040_bib50","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1523\/JNEUROSCI.3597-04.2004","article-title":"High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity","volume":"24","author":"Mark","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.040_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1874473710801020213","article-title":"Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies","volume":"1","author":"Martinez-Raga","year":"2008","journal-title":"Curr. Drug. Abus. Rev."},{"key":"10.1016\/j.ejphar.2016.03.040_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.ejphar.2016.03.040_bib53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1755-5949.2011.00263.x","article-title":"A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial","volume":"18","author":"McCann","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2016.03.040_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40263-014-0142-x","article-title":"Potential role of N-acetylcysteine in the management of substance use disorders","volume":"28","author":"McClure","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2016.03.040_bib55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/00952990802342907","article-title":"Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study","volume":"35","author":"McElhiney","year":"2009","journal-title":"Am. J. Drug. Alcohol Abus."},{"key":"10.1016\/j.ejphar.2016.03.040_bib56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jsat.2007.12.003","article-title":"Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual","volume":"35","author":"McGregor","year":"2008","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.ejphar.2016.03.040_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/02791072.2007.10399875","article-title":"An open-label pilot study of risperidone in the treatment of methamphetamine dependence","volume":"39","author":"Meredith","year":"2007","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.ejphar.2016.03.040_bib58","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/add.12109","article-title":"Extended-release methylphenidate for treatment of amphetamine\/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial","volume":"108","author":"Miles","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2016.03.040_bib59","first-page":"28","article-title":"The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study","volume":"18","author":"Mousavi","year":"2015","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.ejphar.2016.03.040_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/npp.2012.171","article-title":"Occupancy of brain dopamine D3 receptors and drug craving: a translational approach","volume":"38","author":"Mugnaini","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.040_bib61","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","article-title":"The role of serotonin in drug use and addiction","volume":"277","author":"Muller","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.040_bib62","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4088\/JCP.v69n0808","article-title":"Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial","volume":"69","author":"Nejtek","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib63","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bcp.2012.06.023","article-title":"Medication discovery for addiction: translating the dopamine D3 receptor hypothesis","volume":"84","author":"Newman","year":"2012","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib64","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00213-005-0102-8","article-title":"Safety of intravenous methamphetamine administration during treatment with bupropion","volume":"182","author":"Newton","year":"2005","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.ejphar.2016.03.040_bib65","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.npp.1300979","article-title":"Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving","volume":"31","author":"Newton","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.040_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00952990.2013.858723","article-title":"Dopamine D3 receptors as a therapeutic target for methamphetamine dependence","volume":"40","author":"Paterson","year":"2014","journal-title":"Am. J. Drug. Alcohol Abus."},{"key":"10.1016\/j.ejphar.2016.03.040_bib67","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/npp.2012.111","article-title":"Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats","volume":"37","author":"Pelloux","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.040_bib68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopsych.2013.09.028","article-title":"Diminished role of dopamine D1-receptor signaling with the development of an addicted phenotype in rats","volume":"76","author":"Ramoa","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/187152710790966704","article-title":"Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics","volume":"9","author":"Ray","year":"2010","journal-title":"CNS Neurol. Disord. Drug. Targets"},{"key":"10.1016\/j.ejphar.2016.03.040_bib70","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/npp.2015.83","article-title":"The effects of naltrexone on subjective response to methamphetamine in a clinical sample: a double-blind, placebo-controlled laboratory study","volume":"40","author":"Ray","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.040_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.brainresrev.2008.02.004","article-title":"Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway","volume":"58","author":"Rice","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2016.03.040_bib72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1521-0391.2003.tb00653.x","article-title":"Effects of buspirone in withdrawal from opiates","volume":"12","author":"Rose","year":"2003","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.ejphar.2016.03.040_bib73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10401230802177656","article-title":"Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions","volume":"20","author":"Rose","year":"2008","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0022432","article-title":"Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys","volume":"19","author":"Schindler","year":"2011","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2016.03.040_bib76","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2001.96912898.x","article-title":"Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence","volume":"96","author":"Shearer","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2016.03.040_bib77","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug. Alcohol Depend."},{"key":"10.1016\/j.ejphar.2016.03.040_bib78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/FTD.0b013e31823d8e8d","article-title":"Which amphetamine-type stimulants can be detected by oral fluid immunoassays?","volume":"34","author":"Souza","year":"2012","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.ejphar.2016.03.040_bib79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/bc.2011.016","article-title":"The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA,'Ecstasy\u2019), methamphetamine and d-amphetamine","volume":"392","author":"Steinkellner","year":"2011","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.03.040_bib80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijdevneu.2014.12.001","article-title":"The neurotoxicity of amphetamines during the adolescent period","volume":"41","author":"Teixeira-Gomes","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.040_bib81","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/appi.ajp.2011.11071121","article-title":"Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial","volume":"169","author":"Tiihonen","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2016.03.040_bib82","unstructured":"UNODC (United Nations Office on Drugs and Crime), 2015. World Drug Report 2015. United Nations publication, Sales No. E.15.XI.6."},{"key":"10.1016\/j.ejphar.2016.03.040_bib83","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1523\/JNEUROSCI.0925-05.2005","article-title":"Involvement of the dorsal striatum in cue-controlled cocaine seeking","volume":"25","author":"Vanderschuren","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.040_bib84","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2016.03.040_bib85","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2008.05.022","article-title":"Imaging dopamine's role in drug abuse and addiction","volume":"56","author":"Volkow","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2016.03.040_bib86","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","article-title":"Striatal dopamine nerve terminal markers in human, chronic methamphetamine users","volume":"2","author":"Wilson","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2016.03.040_bib87","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.109.153775","article-title":"A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain","volume":"330","author":"Xie","year":"2009","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.03.040_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.07.040","article-title":"Methamphetamine modulates glutamatergic synaptic transmission in rat primary cultured hippocampal neurons","volume":"1582","author":"Zhang","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.040_bib89","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.biopsych.2007.06.008","article-title":"N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking","volume":"63","author":"Zhou","year":"2008","journal-title":"Biol. Psychiatry"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916301704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916301704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T16:50:26Z","timestamp":1583859026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916301704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":89,"alternative-id":["S0014299916301704"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.040","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}